Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NYSE:LOW NYSE:MMM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$248.060.0%$226.15$184.63▼$261.64$438.31B0.39.03 million shs4.14 million shsLOWLowe's Companies$207.73-1.8%$218.57$203.40▼$293.06$118.66B0.862.66 million shs4.26 million shsMMM3M$157.68+0.1%$154.87$139.34▼$177.41$82.16B1.023.16 million shs1.72 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.02%-2.63%+9.02%+17.96%+28.98%LOWLowe's Companies-1.87%-7.18%-5.82%-16.38%-7.31%MMM3M+0.16%-0.94%-0.41%+3.38%+1.25%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$248.060.0%$226.15$184.63▼$261.64$438.31B0.39.03 million shs4.14 million shsLOWLowe's Companies$207.73-1.8%$218.57$203.40▼$293.06$118.66B0.862.66 million shs4.26 million shsMMM3M$157.68+0.1%$154.87$139.34▼$177.41$82.16B1.023.16 million shs1.72 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.02%-2.63%+9.02%+17.96%+28.98%LOWLowe's Companies-1.87%-7.18%-5.82%-16.38%-7.31%MMM3M+0.16%-0.94%-0.41%+3.38%+1.25%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.84Moderate Buy$266.247.33% UpsideLOWLowe's Companies 2.58Moderate Buy$264.5727.36% UpsideMMM3M 2.29Hold$170.007.81% UpsideCurrent Analyst Ratings BreakdownLatest MMM, ABBV, and LOW Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026ABBVAbbVie UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$230.00 ➝ $260.007/13/2026ABBVAbbVie BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$258.00 ➝ $300.007/10/2026ABBVAbbVie Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $295.007/10/2026ABBVAbbVie Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$234.00 ➝ $276.007/10/2026ABBVAbbVie Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$260.00 ➝ $280.007/9/2026MMM3M Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/9/2026ABBVAbbVie GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$249.00 ➝ $261.007/9/2026ABBVAbbVie JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $280.007/6/2026ABBVAbbVie HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$300.007/6/2026ABBVAbbVie Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$240.00 ➝ $265.006/29/2026MMM3M Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$170.00 ➝ $175.00(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$61.16B7.17$15.14 per share16.38($1.83) per share-135.55LOWLowe's Companies$86.29B1.35$15.92 per share13.05($17.68) per share-11.75MMM3M$24.95B3.30$10.68 per share14.76$8.94 per share17.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03122.2015.470.815.79%-576.45%13.39%7/31/2026 (Estimated)LOWLowe's Companies$6.65B$11.8317.5615.422.677.51%-67.96%13.31%8/19/2026 (Estimated)MMM3M$3.25B$5.1930.3816.772.2211.14%104.75%12.03%7/21/2026 (Estimated)Latest MMM, ABBV, and LOW EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/31/2026Q2 2026ABBVAbbVie$3.71N/AN/AN/A$16.78 billionN/A7/21/2026Q2 2026MMM3M$2.27N/AN/AN/A$6.41 billionN/A5/20/2026Q1 2026LOWLowe's Companies$2.97$3.03+$0.06$2.90$22.98 billion$23.08 billion4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion4/21/2026Q1 2026MMM3M$1.98$2.14+$0.16$1.23$6.04 billion$6.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.922.79%+6.80%340.89%53 YearsLOWLowe's Companies$4.802.31%+15.61%40.57%53 YearsMMM3M$3.121.98%-13.06%60.12%1 YearsLatest MMM, ABBV, and LOW DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/18/2026ABBVAbbViequarterly$1.733.19%7/15/20267/15/20268/14/20265/29/2026LOWLowe's Companiesquarterly$1.252.33%7/22/20267/22/20268/5/20265/12/2026MMM3Mquarterly$0.782.04%5/22/20265/22/20266/12/20261/1/2100LOWLowe's Companiesquarterly$1.202.13%7/23/20257/23/20258/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68LOWLowe's CompaniesN/A1.090.18MMM3M3.291.591.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%LOWLowe's Companies74.06%MMM3M65.25%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%LOWLowe's Companies0.29%MMM3M0.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableLOWLowe's Companies276,000560.71 million559.08 millionOptionableMMM3M60,500521.57 million520.58 millionOptionableMMM, ABBV, and LOW HeadlinesRecent News About These Companies3M (MMM) Expected to Announce Earnings on Tuesday1 hour ago | americanbankingnews.com3M (MMM) Expected to Announce Quarterly Earnings on Tuesday1 hour ago | marketbeat.com3M's Consumer Segment's Weakness Persists: What's the Road Ahead?July 10, 2026 | zacks.comWhy Are 3M (NYSE:MMM) Supply Chains Under S&P 500 Spotlight?July 8, 2026 | kalkinemedia.comK3M Announces Upcoming Investor EventJuly 7, 2026 | prnewswire.com3M Young Scientist Challenge Names 10 Finalists for 2026 National CompetitionJuly 6, 2026 | prnewswire.comIs 3M Company (MMM) Stock Undervalued With Growth Trends Improving and Liabilities Easing?July 2, 2026 | finance.yahoo.com3M (MMM) Enters Cadillac Formula 1 Partnership To Put Material Science On DisplayJuly 2, 2026 | finance.yahoo.comIs 3M Company (MMM) Stock Undervalued With Growth Trends Improving and Liabilities Easing?July 2, 2026 | insidermonkey.com3M and Discovery Education announce 37 State Merit Winners and four Honorable Mentions in 2026 3M Young Scientist ChallengeJuly 1, 2026 | prnewswire.com3M joins Cadillac Formula 1® Team as Official Material Science Partner to accelerate racing performanceJune 30, 2026 | prnewswire.comHere’s Why 3M (MMM) is Among the 12 Most Profitable S&P 500 Stocks to Invest InJune 27, 2026 | finance.yahoo.comHere’s Why 3M (MMM) is Among the 12 Most Profitable S&P 500 Stocks to Invest InJune 27, 2026 | insidermonkey.comZacks Industry Outlook 3M, Griffon, GPGI and Public PolicyJune 26, 2026 | zacks.comStrength in Safety & Industrial Unit Drives MMM: Can the Momentum Last?June 25, 2026 | zacks.com4 Diversified Operations Stocks to Consider on Promising Industry TrendsJune 25, 2026 | zacks.com3M (MMM) Signs Long Term Airbus A220 Supply Deal For Aircraft InsulationJune 25, 2026 | finance.yahoo.com3M Secures Long-Term Supply Agreement With Airbus for A220June 24, 2026 | zacks.com3M Secures Long-Term Airbus A220 Insulation Supply Agreement (MMM)June 23, 2026 | investorshub.advfn.com3M and Airbus announce agreement to advance A220 passenger comfort and aircraft performance through advanced insulation technologyJune 23, 2026 | prnewswire.comCurious About 3M (NYSE:MMM)? Here’s What’s Shaping Its Next ChapterJune 22, 2026 | kalkinemedia.comKNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Gravity Check: Houston, SpaceX Has a Valuation ProblemBy Jeffrey Neal Johnson | June 16, 2026Winnebago Misses Estimates, But Surges 14% After EarningsBy Chris Markoch | June 29, 2026Abivax: Wall Street Catches Up to the DataBy Chris Markoch | July 7, 20265 Dividend Kings to Buy in July with Irresistible Value and YieldBy Thomas Hughes | July 8, 2026MMM, ABBV, and LOW Company DescriptionsAbbVie NYSE:ABBV$248.06 -0.02 (-0.01%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$248.10 +0.04 (+0.02%) As of 07/13/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Lowe's Companies NYSE:LOW$207.73 -3.90 (-1.84%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$207.65 -0.08 (-0.04%) As of 07/13/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Lowe's Companies, Inc., together with its subsidiaries, operates as a home improvement retailer in the United States. The company offers a line of products for construction, maintenance, repair, remodeling, and decorating. It also provides home improvement products, such as appliances, seasonal and outdoor living, lawn and garden, lumber, kitchens and bath, tools, paint, millwork, hardware, flooring, rough plumbing, building materials, décor, and electrical. In addition, the company offers installation services through independent contractors in various product categories; and extended protection plans and repair services. It sells its national brand-name merchandise and private brand products to professional customers, homeowners, renters, businesses, and government. The company also sells its products through Lowes.com website; and through mobile applications. Lowe's Companies, Inc. was founded in 1921 and is based in Mooresville, North Carolina.3M NYSE:MMM$157.68 +0.16 (+0.10%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$156.61 -1.07 (-0.68%) As of 07/13/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.3M Company provides diversified technology services in the United States and internationally. The company's Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company's Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
